(MOLN) - FDA

(MOLN) – FDA

Dec 11, 2023 03:51 AM Molecular Partners AG (MOLN) Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533
Jan 17, 2023 05:35 AM Molecular Partners (MOLN) Commences Phase 1 Trial for MP0533
Nov 10, 2022 05:48 AM
Oct 27, 2022 04:00 PM
Jul 21, 2022 11:31 AM
Apr 26, 2022 04:07 PM
Feb 10, 2022 04:41 AM
Jan 18, 2022 05:36 AM
Jan 10, 2022 05:35 AM
Dec 14, 2021 05:43 AM
Dec 13, 2021 05:04 AM
Dec 6, 2021 05:23 AM
Nov 16, 2021 05:51 AM
Oct 28, 2021 05:32 AM
Oct 20, 2021 05:46 AM
Oct 14, 2019 06:13 AM
Apr 2, 2019 07:05 AM
Jul 19, 2018 08:02 AM